NASDAQ: XRAY | Healthcare / Medical Devices & Instruments / USA |
32.21 | +0.0300 | +0.09% | Vol 1.89M | 1Y Perf 6.87% |
Dec 6th, 2023 16:00 DELAYED |
BID | 31.34 | ASK | 33.13 | ||
Open | 32.33 | Previous Close | 32.18 | ||
Pre-Market | - | After-Market | 32.15 | ||
- - | -0.06 -0.19% |
Target Price | 37.60 | Analyst Rating | Moderate Buy 2.25 | |
Potential % | 16.73 | Finscreener Ranking | + 36.76 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-60 | Value Ranking | ★ 39.84 | |
Insiders Value % 3/6/12 mo. | -100/-100/-43 | Growth Ranking | + 32.77 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-41 | Income Ranking | ★★★★ 52.16 | |
Price Range Ratio 52W % | 35.00 | Earnings Rating | Neutral | |
Market Cap | 6.82B | Earnings Date | 2nd Nov 2023 | |
Alpha | -0.01 | Standard Deviation | 0.09 | |
Beta | 0.97 |
Today's Price Range 31.9532.63 | 52W Range 26.2743.24 | 5 Year PE Ratio Range -114.6052.00 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Buy |
Performance | |||
---|---|---|---|
1 Week | 1.45% | ||
1 Month | 13.42% | ||
3 Months | -10.92% | ||
6 Months | -18.23% | ||
1 Year | 6.87% | ||
3 Years | -39.91% | ||
5 Years | -11.29% | ||
10 Years | -31.97% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 2.18 | |||
ROE last 12 Months | -20.27 | |||
ROA (5Y Avg) | 1.34 | |||
ROA last 12 Months | -10.47 | |||
ROC (5Y Avg) | -5.00 | |||
ROC last 12 Months | -11.59 | |||
Return on invested Capital Q | -16.67 | |||
Return on invested Capital Y | 1.51 | |||
Assets Turnover | 0.40 | |||
Receivables Turnover | 4.40 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-8.90 | ||||
1.99 | ||||
2.41 | ||||
12.10 | ||||
39.90 | ||||
2.76 | ||||
-8.49 | ||||
16.81 | ||||
10.21B | ||||
Forward PE | 16.11 | |||
PEG | -1.11 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.80 | ||||
1.50 | ||||
0.34 | ||||
0.59 | ||||
-15.80 | ||||
Leverage Ratio | 1.90 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
54.90 | ||||
-20.70 | ||||
-12.50 | ||||
-8.90 | ||||
-31.81 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.94B | ||||
13.68 | ||||
1.04 | ||||
0.13 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.52 | ||||
0.50 | ||||
6.95 | ||||
5.77 | ||||
Payout ratio | 51.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2023 | 0.48 | 0.49 | 2.08 |
Q02 2023 | 0.43 | 0.51 | 18.60 |
Q01 2023 | 0.33 | 0.39 | 18.18 |
Q04 2022 | 0.32 | 0.46 | 43.75 |
Q03 2022 | 0.59 | 0.41 | -30.51 |
Q01 2022 | 0.50 | 0.52 | 4.00 |
Q04 2021 | 0.79 | 0.76 | -3.80 |
Q03 2021 | 0.65 | 0.68 | 4.62 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
12/2023 QR | 0.44 | -25.42 | Negative |
12/2023 FY | 1.82 | -7.61 | Negative |
3/2024 QR | 0.45 | -10.00 | Negative |
12/2024 FY | 2.02 | -10.62 | Negative |
Next Report Date | - |
Estimated EPS Next Report | 0.48 |
Estimates Count | 9 |
EPS Growth Next 5 Years % | 8.00 |
Volume Overview | |
---|---|
Volume | 1.89M |
Shares Outstanding | 211.86K |
Shares Float | 210.29M |
Trades Count | 25.23K |
Dollar Volume | 61.23M |
Avg. Volume | 4.11M |
Avg. Weekly Volume | 5.40M |
Avg. Monthly Volume | 3.97M |
Avg. Quarterly Volume | 2.94M |
DENTSPLY SIRONA Inc. (NASDAQ: XRAY) stock closed at 32.21 per share at the end of the most recent trading day (a 0.09% change compared to the prior day closing price) with a volume of 1.89M shares and market capitalization of 6.82B. Is a component of S&P 500, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 15000 people. DENTSPLY SIRONA Inc. CEO is Donald M. Casey.
The one-year performance of DENTSPLY SIRONA Inc. stock is 6.87%, while year-to-date (YTD) performance is 1.16%. XRAY stock has a five-year performance of -11.29%. Its 52-week range is between 26.27 and 43.24, which gives XRAY stock a 52-week price range ratio of 35.00%
DENTSPLY SIRONA Inc. currently has a PE ratio of -8.90, a price-to-book (PB) ratio of 1.99, a price-to-sale (PS) ratio of 2.41, a price to cashflow ratio of 12.10, a PEG ratio of -1.11, a ROA of -10.47%, a ROC of -11.59% and a ROE of -20.27%. The company’s profit margin is -31.81%, its EBITDA margin is -12.50%, and its revenue ttm is $2.94 Billion , which makes it $13.68 revenue per share.
Of the last four earnings reports from DENTSPLY SIRONA Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.48 for the next earnings report. DENTSPLY SIRONA Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for DENTSPLY SIRONA Inc. is Moderate Buy (2.25), with a target price of $37.6, which is +16.73% compared to the current price. The earnings rating for DENTSPLY SIRONA Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
DENTSPLY SIRONA Inc. has a dividend yield of 1.52% with a dividend per share of $0.50 and a payout ratio of 51.00%.
DENTSPLY SIRONA Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 14.34, ATR14 : 0.91, CCI20 : 86.90, Chaikin Money Flow : 0.12, MACD : 0.42, Money Flow Index : 84.11, ROC : 8.49, RSI : 59.31, STOCH (14,3) : 75.83, STOCH RSI : 0.41, UO : 59.61, Williams %R : -24.17), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of DENTSPLY SIRONA Inc. in the last 12-months were: Campion Simon (Buy at a value of $297 000), Coleman Glenn (Buy at a value of $297 000), Cord Friedrich Staehler (Sold 4 000 shares of value $157 320 ), Eric K. Brandt (Option Excercise at a value of $257 114), Eric K. Brandt (Sold 6 200 shares of value $261 454 ), Lucier Gregory (Buy at a value of $314 400), Staehler Cord (Sold 4 000 shares of value $157 320 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Moderate Buy | Moderate Buy |
Dentsply Sirona is a leading global manufacturer and distributor of dental supplies and equipment. Its product segments include dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation.
CEO: Donald M. Casey
Telephone: +1 844 848-0137
Address: 13320 Ballantyne Corporate Place, Charlotte 28277-3607, NC, US
Number of employees: 15 000
Mon, 06 Nov 2023 11:00 GMT Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT), DENTSPLY SIRONA (XRAY) and Morphosys Ag (MOR)
- TipRanks. All rights reserved.Thu, 02 Nov 2023 04:20 GMT Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY) and Pfizer (PFE)
- TipRanks. All rights reserved.Wed, 11 Oct 2023 12:48 GMT Dentsply Sirona price target lowered to $36 from $45 at Evercore ISI
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.